# Clinical Validation of the RENISCHEM L-FABP POC Assay

> **NCT04864847** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hikari Dx, Inc.** · enrollment: 450 (estimated)

## Conditions studied

- Acute Kidney Injury
- Contrast-induced Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** RENISCHEM L-FABP POC Test

## Key facts

- **NCT ID:** NCT04864847
- **Lead sponsor:** Hikari Dx, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-01
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864847, "Clinical Validation of the RENISCHEM L-FABP POC Assay". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04864847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*